Home › NDC Lookup › RxCUI directory › RxCUI 855626

Twice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch — RxCUI 855626

RxNorm drug concept · Semantic clinical drug
RxCUI 855626 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI855626
Official nameTwice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiclofenac epolamine 1.3 % Twice-Daily Medicated Patch
FDA products mapped11
Package NDCs mapped14
Reported Medicaid activity (SDUD)21,190 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They calm inflammation after cataract surgery. They also temporarily ease pain and light sensitivity after corneal refractive surgery, such as PRK or radial keratotomy.
  • After cataract surgery, it is usually about 4 times a day, starting the day after surgery for the first 2 weeks. For refractive surgery, you use drops before and right after the pr...
  • Brief burning or stinging is the most common complaint, affecting about 15% of people. It usually passes quickly. Tell your doctor if it persists or you notice blurred vision, redn...
  • Be careful and tell your doctor first. People sensitive to aspirin or other NSAIDs may also react to diclofenac. You should not use the drops if you are allergic to any ingredient...
📖 Read our full Diclofenac Ophthalmic guide →

🕸️ Concept Web — How Twice-Daily diclofenac epolamine 0.013 MG/MG Med... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Twice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch RxCUI 855626

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Diclofenac 3355
    • Diclofenac epolamine 40968
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Flector 135123
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diclofenac Medicated Patch 1792846
    • Diclofenac epolamine Medicated Patch 2646698
    • Diclofenac Topical Product 1151155
    • Diclofenac epolamine Topical Product 2663267
    • Diclofenac Medicated Patch [Flector] 1792849
    • Diclofenac epolamine Medicated Patch [Flector] 2658327
    • Flector Topical Product 1169035
    • Medicated Patch 1792831
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diclofenac epolamine 0.013 MG/MG SCDC · 1792845
  • Diclofenac Medicated Patch SCDF · 1792846
  • Diclofenac epolamine Medicated Patch SCDFP · 2646698
  • Diclofenac Topical Product SCDG · 1151155
  • Diclofenac epolamine Topical Product SCDGP · 2663267

Brand-Name Concepts

📦 FDA Products & Package NDCs

11 products · 14 package NDCs
14 package NDCs map to RxCUI 855626 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3727-55 6 POUCH in 1 CARTON (0093-3727-55) / 5 SYSTEM in 1 POUCH (0... diclofenac epolamine Teva Pharmaceuticals USA Inc. 2020-05-01
68788-4115-03 6 POUCH in 1 CARTON (68788-4115-3) / 5 SYSTEM in 1 POUCH Diclofenac Epolamine Preferred Pharmaceuticals Inc. 2026-06-08
71858-0405-02 1 POUCH in 1 CARTON (71858-0405-2) / 2 SYSTEM in 1 POUCH (7... FLECTOR IBSA Pharma Inc. 2020-11-01
71858-0405-05 6 POUCH in 1 CARTON (71858-0405-5) / 5 SYSTEM in 1 POUCH (7... FLECTOR IBSA Pharma Inc. 2020-11-01
71858-0405-06 3 POUCH in 1 CARTON (71858-0405-6) / 5 SYSTEM in 1 POUCH (7... FLECTOR IBSA Pharma Inc. 2026-02-01
76420-0409-30 6 POUCH in 1 CARTON (76420-409-30) / 5 SYSTEM in 1 POUCH diclofenac epolamine ASCLEMED USA INC. 2025-06-25
76420-0673-30 6 POUCH in 1 CARTON (76420-673-30) / 5 SYSTEM in 1 POUCH Diclofenac Epolamine Asclemed USA, Inc. 2024-02-26
80425-0364-01 6 POUCH in 1 CARTON (80425-0364-1) / 5 SYSTEM in 1 POUCH diclofenac epolamine Advanced Rx of Tennessee, LLC 2023-11-27
80425-0403-01 6 POUCH in 1 CARTON (80425-0403-1) / 5 SYSTEM in 1 POUCH Diclofenac Epolamine Advanced Rx Pharmacy of Tennessee, LLC 2024-06-19
82347-0405-05 6 POUCH in 1 CARTON (82347-0405-5) / 5 SYSTEM in 1 POUCH (8... Diclofenac Epolamine YARAL Pharma Inc. 2022-11-18
82347-0405-06 3 POUCH in 1 CARTON (82347-0405-6) / 5 SYSTEM in 1 POUCH (8... Diclofenac Epolamine YARAL Pharma Inc. 2025-01-15
83008-0036-30 6 POUCH in 1 CARTON (83008-036-30) / 5 SYSTEM in 1 POUCH diclofenac epolamine Quality Care Products, LLC 2023-08-15
85509-1405-03 6 POUCH in 1 CARTON (85509-1405-3) / 5 SYSTEM in 1 POUCH Diclofenac Epolamine Phoenix RX LLC 2025-09-27
87234-0405-05 6 POUCH in 1 CARTON (87234-0405-5) / 5 SYSTEM in 1 POUCH (8... Diclox Patch 30CT Injecta Medcial LLC 2026-05-22
Observed labelers: IBSA Pharma Inc. (3) · YARAL Pharma Inc. (2) · Advanced Rx of Tennessee, LLC (1) · Advanced Rx Pharmacy of Tennessee, LLC (1) · ASCLEMED USA INC. (1) · Asclemed USA, Inc. (1) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$4.9562
Range $4.9562–$4.9562 · middle 50% $4.9562–$4.9562 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.